Global Prostate Cancer Therapeutic Market Research Report 2016

Global Prostate Cancer Therapeutic Market Research Report 2016

1 Prostate Cancer Therapeutic Market Overview

1.1 Product Overview and Scope of Prostate Cancer Therapeutic

1.2 Prostate Cancer Therapeutic Segment by Type

1.2.1 Global Production Market Share of Prostate Cancer Therapeutic by Type in 2015

1.2.2 Type I

1.2.3 Type II

1.2.4 Type III

1.3 Prostate Cancer Therapeutic Segment by Application

1.3.1 Prostate Cancer Therapeutic Consumption Market Share by Application in 2015

1.3.2 Application 1

1.3.3 Application 2

1.3.4 Application 3

1.4 Prostate Cancer Therapeutic Market by Region

1.4.1 North America Status and Prospect (2011-2021)

1.4.2 Europe Status and Prospect (2011-2021)

1.4.3 China Status and Prospect (2011-2021)

1.4.4 Japan Status and Prospect (2011-2021)

1.4.5 Southeast Asia Status and Prospect (2011-2021)

1.4.6 India Status and Prospect (2011-2021)

1.5 Global Market Size (Value) of Prostate Cancer Therapeutic (2011-2021)

2 Global Prostate Cancer Therapeutic Market Competition by Manufacturers

2.1 Global Prostate Cancer Therapeutic Production and Share by Manufacturers (2015 and 2016)

2.2 Global Prostate Cancer Therapeutic Revenue and Share by Manufacturers (2015 and 2016)

2.3 Global Prostate Cancer Therapeutic Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Prostate Cancer Therapeutic Manufacturing Base Distribution, Sales Area and Product Type

2.5 Prostate Cancer Therapeutic Market Competitive Situation and Trends

2.5.1 Prostate Cancer Therapeutic Market Concentration Rate

2.5.2 Prostate Cancer Therapeutic Market Share of Top 3 and Top 5 Manufacturers

2.5.3 Mergers & Acquisitions, Expansion

3 Global Prostate Cancer Therapeutic Production, Revenue (Value) by Region (2011-2016)

3.1 Global Prostate Cancer Therapeutic Production and Market Share by Region (2011-2016)

3.2 Global Prostate Cancer Therapeutic Revenue (Value) and Market Share by Region (2011-2016)

3.3 Global Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

3.4 North America Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

3.5 Europe Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

3.6 China Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

3.7 Japan Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

3.8 Southeast Asia Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

3.9 India Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

4 Global Prostate Cancer Therapeutic Supply (Production), Consumption, Export, Import by Regions (2011-2016)

4.1 Global Prostate Cancer Therapeutic Consumption by Regions (2011-2016)

4.2 North America Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

4.3 Europe Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

4.4 China Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

4.5 Japan Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

4.6 Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

4.7 India Prostate Cancer Therapeutic Production, Consumption, Export, Import by Regions (2011-2016)

5 Global Prostate Cancer Therapeutic Production, Revenue (Value), Price Trend by Type

5.1 Global Prostate Cancer Therapeutic Production and Market Share by Type (2011-2016)

5.2 Global Prostate Cancer Therapeutic Revenue and Market Share by Type (2011-2016)

5.3 Global Prostate Cancer Therapeutic Price by Type (2011-2016)

5.4 Global Prostate Cancer Therapeutic Production Growth by Type (2011-2016)

6 Global Prostate Cancer Therapeutic Market Analysis by Application

6.1 Global Prostate Cancer Therapeutic Consumption and Market Share by Application (2011-2016)

6.2 Global Prostate Cancer Therapeutic Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Applications

6.3.2 Emerging Markets/Countries

7 Global Prostate Cancer Therapeutic Manufacturers Profiles/Analysis

7.1 Pfizer Inc. (USA)

7.1.1 Company Basic Information, Manufacturing Base and Its Competitors

7.1.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.1.2.1 Type I

7.1.2.2 Type II

7.1.3 Pfizer Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.1.4 Main Business/Business Overview

7.2 Abbott Laboratories (USA)

7.2.1 Company Basic Information, Manufacturing Base and Its Competitors

7.2.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.2.2.1 Type I

7.2.2.2 Type II

7.2.3 Abbott Laboratories (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.2.4 Main Business/Business Overview

7.3 Genentech Inc. (USA)

7.3.1 Company Basic Information, Manufacturing Base and Its Competitors

7.3.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.3.2.1 Type I

7.3.2.2 Type II

7.3.3 Genentech Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.3.4 Main Business/Business Overview

7.4 GlaxoSmithKline Plc (UK)

7.4.1 Company Basic Information, Manufacturing Base and Its Competitors

7.4.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.4.2.1 Type I

7.4.2.2 Type II

7.4.3 GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.4.4 Main Business/Business Overview

7.5 Immunomedics, Inc. (USA)

7.5.1 Company Basic Information, Manufacturing Base and Its Competitors

7.5.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.5.2.1 Type I

7.5.2.2 Type II

7.5.3 Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.5.4 Main Business/Business Overview

7.6 Indevus Pharmaceuticals Inc. (USA)

7.6.1 Company Basic Information, Manufacturing Base and Its Competitors

7.6.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.6.2.1 Type I

7.6.2.2 Type II

7.6.3 Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.6.4 Main Business/Business Overview

7.7 Novartis AG (Switzerland)

7.7.1 Company Basic Information, Manufacturing Base and Its Competitors

7.7.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.7.2.1 Type I

7.7.2.2 Type II

7.7.3 Novartis AG (Switzerland) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.7.4 Main Business/Business Overview

7.8 OSI Pharmaceuticals, Inc. (USA)

7.8.1 Company Basic Information, Manufacturing Base and Its Competitors

7.8.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.8.2.1 Type I

7.8.2.2 Type II

7.8.3 OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.8.4 Main Business/Business Overview

7.9 Paladin Labs Inc. (Canada)

7.9.1 Company Basic Information, Manufacturing Base and Its Competitors

7.9.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.9.2.1 Type I

7.9.2.2 Type II

7.9.3 Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.9.4 Main Business/Business Overview

7.10 ALZA Corporation (USA)

7.10.1 Company Basic Information, Manufacturing Base and Its Competitors

7.10.2 Prostate Cancer Therapeutic Product Type, Application and Specification

7.10.2.1 Type I

7.10.2.2 Type II

7.10.3 ALZA Corporation (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2015 and 2016)

7.10.4 Main Business/Business Overview

7.11 Amgen Inc. (USA)

7.12 AstraZeneca PLC (UK)

7.13 Medimmune, LLC (USA)

7.14 Bristol-Myers Squibb Company (USA)

7.15 Cell Genesys Inc. (USA)

7.16 Dendreon Corporation (USA)

7.17 EUSA Pharma, (USA) Inc. (USA)

7.18 F. Hoffmann-La Roche Ltd. (Switzerland)

7.19 Progenics Pharmaceuticals, Inc. (USA)

7.20 Sanofi-Aventis SA (France)

7.21 Spectrum Pharmaceuticals, Inc. (USA)

7.22 Takeda Pharmaceutical Company Limited (Japan)

8 Prostate Cancer Therapeutic Manufacturing Cost Analysis

8.1 Prostate Cancer Therapeutic Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Prostate Cancer Therapeutic

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Prostate Cancer Therapeutic Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 Global Prostate Cancer Therapeutic Market Forecast (2016-2021)

12.1 Global Prostate Cancer Therapeutic Production, Revenue Forecast (2016-2021)

12.2 Global Prostate Cancer Therapeutic Production, Consumption Forecast by Regions (2016-2021)

12.3 Global Prostate Cancer Therapeutic Production Forecast by Type (2016-2021)

12.4 Global Prostate Cancer Therapeutic Consumption Forecast by Application (2016-2021)

12.5 Prostate Cancer Therapeutic Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Author List

Disclosure Section

Research Methodology

Data Source

China Disclaimer

Figure Picture of Prostate Cancer Therapeutic

Figure Global Production Market Share of Prostate Cancer Therapeutic by Type in 2015

Figure Product Picture of Type I

Table Major Manufacturers of Type I

Figure Product Picture of Type II

Table Major Manufacturers of Type II

Figure Product Picture of Type III

Table Major Manufacturers of Type III

Table Prostate Cancer Therapeutic Consumption Market Share by Application in 2015

Figure Application 1 Examples

Figure Application 2 Examples

Figure Application 3 Examples

Figure North America Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)

Figure Europe Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)

Figure China Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)

Figure Japan Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)

Figure Southeast Asia Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)

Figure India Prostate Cancer Therapeutic Revenue (Million USD) and Growth Rate (2011-2021)

Figure Global Prostate Cancer Therapeutic Revenue (Million UDS) and Growth Rate (2011-2021)

Table Global Prostate Cancer Therapeutic Production of Key Manufacturers (2015 and 2016)

Table Global Prostate Cancer Therapeutic Production Share by Manufacturers (2015 and 2016)

Figure 2015 Prostate Cancer Therapeutic Production Share by Manufacturers

Figure 2016 Prostate Cancer Therapeutic Production Share by Manufacturers

Table Global Prostate Cancer Therapeutic Revenue (Million USD) by Manufacturers (2015 and 2016)

Table Global Prostate Cancer Therapeutic Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers

Table 2016 Global Prostate Cancer Therapeutic Revenue Share by Manufacturers

Table Global Market Prostate Cancer Therapeutic Average Price of Key Manufacturers (2015 and 2016)

Figure Global Market Prostate Cancer Therapeutic Average Price of Key Manufacturers in 2015

Table Manufacturers Prostate Cancer Therapeutic Manufacturing Base Distribution and Sales Area

Table Manufacturers Prostate Cancer Therapeutic Product Type

Figure Prostate Cancer Therapeutic Market Share of Top 3 Manufacturers

Figure Prostate Cancer Therapeutic Market Share of Top 5 Manufacturers

Table Global Prostate Cancer Therapeutic Production by Regions (2011-2016)

Figure Global Prostate Cancer Therapeutic Production and Market Share by Regions (2011-2016)

Figure Global Prostate Cancer Therapeutic Production Market Share by Regions (2011-2016)

Figure 2015 Global Prostate Cancer Therapeutic Production Market Share by Regions

Table Global Prostate Cancer Therapeutic Revenue by Regions (2011-2016)

Table Global Prostate Cancer Therapeutic Revenue Market Share by Regions (2011-2016)

Table 2015 Global Prostate Cancer Therapeutic Revenue Market Share by Regions

Table Global Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Table North America Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Table Europe Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Table China Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Table Japan Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Table India Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Table Global Prostate Cancer Therapeutic Consumption Market by Regions (2011-2016)

Table Global Prostate Cancer Therapeutic Consumption Market Share by Regions (2011-2016)

Figure Global Prostate Cancer Therapeutic Consumption Market Share by Regions (2011-2016)

Figure 2015 Global Prostate Cancer Therapeutic Consumption Market Share by Regions

Table North America Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)

Table Europe Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)

Table China Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)

Table Japan Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)

Table Southeast Asia Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)

Table India Prostate Cancer Therapeutic Production, Consumption, Import & Export (2011-2016)

Table Global Prostate Cancer Therapeutic Production by Type (2011-2016)

Table Global Prostate Cancer Therapeutic Production Share by Type (2011-2016)

Figure Production Market Share of Prostate Cancer Therapeutic by Type (2011-2016)

Figure 2015 Production Market Share of Prostate Cancer Therapeutic by Type

Table Global Prostate Cancer Therapeutic Revenue by Type (2011-2016)

Table Global Prostate Cancer Therapeutic Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Prostate Cancer Therapeutic by Type (2011-2016)

Figure 2015 Revenue Market Share of Prostate Cancer Therapeutic by Type

Table Global Prostate Cancer Therapeutic Price by Type (2011-2016)

Figure Global Prostate Cancer Therapeutic Production Growth by Type (2011-2016)

Table Global Prostate Cancer Therapeutic Consumption by Application (2011-2016)

Table Global Prostate Cancer Therapeutic Consumption Market Share by Application (2011-2016)

Figure Global Prostate Cancer Therapeutic Consumption Market Share by Application in 2015

Table Global Prostate Cancer Therapeutic Consumption Growth Rate by Application (2011-2016)

Figure Global Prostate Cancer Therapeutic Consumption Growth Rate by Application (2011-2016)

Table Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)

Table Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Abbott Laboratories (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure Abbott Laboratories (USA) Prostate Cancer Therapeutic Market Share (2011-2016)

Table Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Genentech Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure Genentech Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)

Table GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure GlaxoSmithKline Plc (UK) Prostate Cancer Therapeutic Market Share (2011-2016)

Table Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure Immunomedics, Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)

Table Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure Indevus Pharmaceuticals Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)

Table Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis AG (Switzerland) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis AG (Switzerland) Prostate Cancer Therapeutic Market Share (2011-2016)

Table OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure OSI Pharmaceuticals, Inc. (USA) Prostate Cancer Therapeutic Market Share (2011-2016)

Table Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure Paladin Labs Inc. (Canada) Prostate Cancer Therapeutic Market Share (2011-2016)

Table ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table ALZA Corporation (USA) Prostate Cancer Therapeutic Production, Revenue, Price and Gross Margin (2011-2016)

Figure ALZA Corporation (USA) Prostate Cancer Therapeutic Market Share (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Prostate Cancer Therapeutic

Figure Manufacturing Process Analysis of Prostate Cancer Therapeutic

Figure Prostate Cancer Therapeutic Industrial Chain Analysis

Table Raw Materials Sources of Prostate Cancer Therapeutic Major Manufacturers in 2015

Table Major Buyers of Prostate Cancer Therapeutic

Table Distributors/Traders List

Figure Global Prostate Cancer Therapeutic Production and Growth Rate Forecast (2016-2021)

Figure Global Prostate Cancer Therapeutic Revenue and Growth Rate Forecast (2016-2021)

Table Global Prostate Cancer Therapeutic Production Forecast by Regions (2016-2021)

Table Global Prostate Cancer Therapeutic Consumption Forecast by Regions (2016-2021)

Table Global Prostate Cancer Therapeutic Production Forecast by Type (2016-2021)

Table Global Prostate Cancer Therapeutic Consumption Forecast by Application (2016-2021)